Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has informed BSE that its trading window for dealing in company shares will remain closed from 1st October 2025 until 48 hours after the declaration of the Unaudited Financial Results for the quarter ended 30th September 2025. The trading window closure applies to all Board Members, Promoters, and Designated/Specified Connected Persons of the company, in compliance with SEBI's Insider Trading Regulations, 2015. The date of the Board Meeting to approve these quarterly results will be announced later. The notice was signed by Sudhir Sethi (DIN: 00090172) on 30th September 2025.
This is a routine compliance filing with no direct impact on shareholders. It signals that Q2 FY26 results will be announced soon, which could be a stock-moving event. Insiders are barred from trading during this blackout period to prevent leakage of unpublished financial data.